Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of SUSTOL, ZYNRELEF, and CINVANTI. Its pipeline product is HTX-011. Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of SUSTOL, ZYNRELEF, and CINVANTI. Its pipeline product is HTX-011.
Heron Therapeutics Announces Corporate Headquarters Relocation to Cary, North Carolina PR Newswire SAN DIEGO, Dec. 23, 2024 SAN DIEGO, Dec. 23, 2024 /PRNewswire/ -- Heron Therapeutics, Inc...
U.S. District Court Upholds Validity of CINVANTI® Patents PR Newswire SAN DIEGO, Dec. 3, 2024 — Court Rules in Favor of Heron in Patent Lawsuit Against Fresenius Kabi USA, LLC — SAN DIEGO, Dec...
Heron Therapeutics Announces Third Quarter 2024 Financial Results and Narrows Financial Guidance PR Newswire SAN DIEGO, Nov. 12, 2024 Reported positive YTD 2024 Adjusted EBITDA of $1.4...
Heron Therapeutics Announces Appointment of Michael Kaseta to Board of Directors PR Newswire SAN DIEGO, Nov. 4, 2024 SAN DIEGO, Nov. 4, 2024 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq:...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.18 | -10.7142857143 | 1.68 | 1.69 | 1.46 | 1096022 | 1.53485259 | CS |
4 | -0.15 | -9.09090909091 | 1.65 | 1.83 | 1.46 | 1705475 | 1.59273817 | CS |
12 | -0.28 | -15.7303370787 | 1.78 | 1.995 | 1.04 | 3329048 | 1.55312737 | CS |
26 | -1.79 | -54.4072948328 | 3.29 | 3.73 | 1.04 | 2640039 | 1.83926669 | CS |
52 | -0.65 | -30.2325581395 | 2.15 | 3.93 | 1.04 | 2566445 | 2.31938336 | CS |
156 | -6.98 | -82.3113207547 | 8.48 | 9.45 | 0.5 | 2573393 | 2.76616425 | CS |
260 | -21.12 | -93.3687002653 | 22.62 | 25.03 | 0.5 | 2066249 | 5.827232 | CS |
Symbole | Prix | Vol. |
---|---|---|
TNXPTonix Pharmaceuticals Holding Corporation | US$ 0,26995 (16,21%) | 27,41M |
RIMEAlgorhythm Holdings Inc | US$ 0,0419 (-16,53%) | 19,13M |
ACONAclarion Inc | US$ 0,0446 (4,94%) | 8,84M |
SLXNSilexion Therapeutics Corporation | US$ 2,61 (67,31%) | 7,5M |
BHATBlue Hat Interactive Entertainment Technology | US$ 0,065 (0,62%) | 4,9M |
Aucune Discussion Trouvée |
Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales